Trial Profile
Austrian Cholesterol Screening And Treatment II (Act II)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Feb 2022
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms ACT-II
- Sponsors Merck & Co; Organon
- 21 Mar 2012 Company (Merck & Co) added as trial sponsor as reported by ClinicalTrials.gov.
- 29 Jun 2011 New trial record